Yale-developed Scorecard Promotes Better Clinical Trial Data Sharing
A tool developed by researchers at Yale, Stanford, and Bioethics International can promote greater sharing of clinical trial data by pharmaceutical companies. While nearly one-third of the companies that the researchers assessed met standards for sharing data, others could be more transparent to the benefit of science and the public, the researchers said.
Yale professor re-appointed to World Economic Forum
Yale School of Medicine Assistant Professor Jennifer Miller has been re-appointed to the World Economic Forum. The forum is made up of 38 councils, each with 20 experts from academia, government, non-governmental organizations, and industry. These councils aim to challenge assumptions and introduce fresh ideas across varying topic areas to reshape global systems for the benefit of humanity and the planet. Dr. Miller will serve on the Global Future Council on Biotechnology.Source: YaleNews
Good Pharma Scorecard Continues to Boost Clinical Trial Transparency, Analyst Report Shows
Calls for increased transparency in clinical trials have been growing and now many medical journals are requiring authors of submitted papers to disclose whether or not they will be sharing clinical trial results.Source: Biospace
Some Big Pharmas stepped up their game on data transparency — but which flunked the test?
The nonprofit Bioethics International has come out with their latest scorecard on data transparency among the big biopharmas in the industry — flagging a few standouts while spotlighting some laggards who are continuing to underperform.Source: Endpoints News